Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients

University of Zurich (UZH)

Status and phase: Completed; Phase 4

Conditions: Skin Cancer

Treatments: Drug: Discontinuation of Azathioprin

Study type: Interventional

Funder types: Other

Identifiers

NCT00492895

2007DR2040

Details and patient eligibility

About

Photosensitivity of the skin to UVA and UVB will be determined

Full description

Photosensitivity of the skin to UVA and UVB in renal transplant recipients with and without azathioprine will be determined. Azathioprine will be discontinued and photosensitivity determined after a wash-out period of three months

• Trial with medicinal product

Enrollment: 25 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Renal transplant recipients under azathioprin

Exclusion criteria

• Treatment with Prograf (Tacrolimus)

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

25 participants in 1 patient group

A

Other group

Description:

one arm only. Crossover study

Treatment:

Drug: Discontinuation of Azathioprin